GlassScriptPhysician profile
Thu Huy Le
NPI 1396846317
$21,673.37
in general payments reported to CMS, 2019-2025
7 companies · $8,179 in 2025
The $8,179 reported for 2025 was more than what 95% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $7,150 · 2021: $124 · 2022: $1,698 · 2023: $4,126 · 2024: $137 · 2025: $8,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $227 · Education: $147 · Travel and Lodging: $61.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,006.50 |
| Food and Beverage | $227.22 |
| Education | $146.50 |
| Travel and Lodging | $61.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $8,093.15 | 2025 | Uplizna |
| Astrazeneca Pharmaceuticals LP | $7,052.42 | 2020 | |
| Becton, Dickinson and Company | $5,820.00 | 2022-2023 | |
| Vifor Pharma, INC. | $357.85 | 2019-2020 | |
| Travere Therapeutics, INC. | $225.73 | 2023-2025 | Filspari |
| Bayer Healthcare Pharmaceuticals INC. | $124.22 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thu Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.